METCELA, a company specializing in cardiac regeneration therapy, has successfully completed a funding round for Series C, raising 1.87 billion yen.
Please see below for details.
News
Notice of investment in METCELANotice of investment in METCELA
プレスリリースPress release
2022.6.282022.6.28
記事をシェアShare this article
関連記事Related articles
FINCHI Inc. Co-Creates New Media "GOETHE Finance powered by FINCHI" with Gentosha’s "GOETHE"FINCHI Inc. Co-Creates New Media "GOETHE Finance powered by FINCHI" with Gentosha’s "GOETHE"
プレスリリースPress release2026.6.252026.6.25
Japan’s First Feasibility Verification of NVIDIA GR00T N1.7 Begins in the Nursing Care SectorJapan’s First Feasibility Verification of NVIDIA GR00T N1.7 Begins in the Nursing Care Sector
プレスリリースPress release2026.6.22026.6.2
Announces Over 80 MOUs Signed for Nursing Assistant Robot R&DAnnounces Over 80 MOUs Signed for Nursing Assistant Robot R&D
プレスリリースPress release2026.3.242026.3.24
新着記事New articles
FINCHI Inc. Co-Creates New Media "GOETHE Finance powered by FINCHI" with Gentosha’s "GOETHE"FINCHI Inc. Co-Creates New Media "GOETHE Finance powered by FINCHI" with Gentosha’s "GOETHE"
プレスリリースPress release2026.6.252026.6.25
Japan’s First Feasibility Verification of NVIDIA GR00T N1.7 Begins in the Nursing Care SectorJapan’s First Feasibility Verification of NVIDIA GR00T N1.7 Begins in the Nursing Care Sector
プレスリリースPress release2026.6.22026.6.2
OpenArm 2.0 Release AnnouncementOpenArm 2.0 Release Announcement
お知らせNotices2026.5.192026.5.19
